For: | Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010; 16(5): 531-537 [PMID: 20128019 DOI: 10.3748/wjg.v16.i5.531] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i5/531.htm |
Number | Citing Articles |
1 |
Qiang Fu, Jun Zhang, Xin Xu, Fei Qian, Ke Feng, Jie Ma. miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5. Tumor Biology 2016; 37(12): 15989 doi: 10.1007/s13277-016-5438-7
|
2 |
Zi-Jun Xie, Gang Chen, Xu-Chao Zhang, Dong-Feng Li, Jian Huang, Zi-Jun Li. Saliva Supernatant miR-21: a Novel Potential Biomarker for Esophageal Cancer Detection. Asian Pacific Journal of Cancer Prevention 2012; 13(12): 6145 doi: 10.7314/APJCP.2012.13.12.6145
|
3 |
Yichao Hou, Qiang Hu, Jiao Huang, Hua Xiong. Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett’s Esophagus Cells. Frontiers in Pharmacology 2018; 8 doi: 10.3389/fphar.2017.00968
|
4 |
Vandan Patel, Steven Ma, Rena Yadlapati. Salivary biomarkers and esophageal disorders. Diseases of the Esophagus 2022; 35(7) doi: 10.1093/dote/doac018
|
5 |
Su Q. Li, He M. Wang, Xiu F. Cao. Potential clinical insights into microRNAs and their target genes in esophageal carcinoma. Biomarkers 2011; 16(8): 629 doi: 10.3109/1354750X.2011.608132
|
6 |
Zhiyu Dong, Junwen Wang, Haiqin Zhang, Tingting Zhan, Ying Chen, Shuchang Xu. Identification of potential key genes in esophageal adenocarcinoma using bioinformatics. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7973
|
7 |
Liu Hong, Yu Han, Shujun Li, Jianjun Yang, Jianyong Zheng, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu, Daiming Fan. The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opinion on Biological Therapy 2010; 10(12): 1693 doi: 10.1517/14712598.2010.532482
|
8 |
Juanjuan Xu, Zhongyuan Yin, Lin Yang, Feng Wu, Jinshuo Fan, Qi Huang, Yang Jin, Guanghai Yang. Evidence that dysplasia related microRNAs in Barrett’s esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma. Aging 2020; 12(17): 17062 doi: 10.18632/aging.103634
|
9 |
Sebastien Haiart, David I Watson, Mary P Leong, David Astill, Tim Bright, Damian J Hussey. MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux. BMC Research Notes 2011; 4(1) doi: 10.1186/1756-0500-4-41
|
10 |
Hao Chen, Yu Fang, Whitney Tevebaugh, Roy C. Orlando, Nicholas J. Shaheen, Xiaoxin Chen. Molecular Mechanisms of Barrett’s Esophagus. Digestive Diseases and Sciences 2011; 56(12): 3405 doi: 10.1007/s10620-011-1885-6
|
11 |
Yanying Wang, Qingxiu Wang, Na Zhang, Hong Ma, Yuchun Gu, Hongming Tang, Zengguang Xu, Yong Gao. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis. Tumor Biology 2014; 35(11): 11595 doi: 10.1007/s13277-014-2350-x
|
12 |
Xiaobo Li, Caitlin Wainscott, Yaguang Xi. MicroRNA provides insight into understanding esophageal cancer. Thoracic Cancer 2011; 2(4): 134 doi: 10.1111/j.1759-7714.2011.00059.x
|
13 |
A. Russo, G. Bronte, D. Cabibi, V. Bazan, G. Cicero, A. Bertani, S. Rizzo, E. Fiorentino. The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg?. Critical Reviews in Oncology/Hematology 2013; 86(3): 278 doi: 10.1016/j.critrevonc.2012.12.001
|
14 |
Puja Gaur, Clayton R. Hunt, Tej K. Pandita. Emerging therapeutic targets in esophageal adenocarcinoma. Oncotarget 2016; 7(30): 48644 doi: 10.18632/oncotarget.8777
|
15 |
Zijun Xie, Gang Chen, Xuchao Zhang, Dongfeng Li, Jian Huang, Cuiqin Yang, Pingyong Zhang, Yuxuan Qin, Yifan Duan, Bo Gong, Zijun Li, Anthony W. I. Lo. Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer. PLoS ONE 2013; 8(4): e57502 doi: 10.1371/journal.pone.0057502
|
16 |
Frank I. Scott, John P. Lynch. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 3 doi: 10.1007/978-1-4614-6015-2_1
|
17 |
Isotta Bozzarelli, Arianna Orsini, Federica Isidori, Luca Mastracci, Deborah Malvi, Marialuisa Lugaresi, Silvia Fittipaldi, Livia Gozzellino, Annalisa Astolfi, Jari Räsänen, Antonia D’Errico, Riccardo Rosati, Roberto Fiocca, Marco Seri, Kausilia K. Krishnadath, Elena Bonora, Sandro Mattioli. miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma. Cancers 2024; 16(3): 591 doi: 10.3390/cancers16030591
|
18 |
Thomas X. Lu, Joseph D. Sherrill, Ting Wen, Andrew J. Plassard, John A. Besse, Juan Pablo Abonia, James P. Franciosi, Philip E. Putnam, Michael Eby, Lisa J. Martin, Bruce J. Aronow, Marc E. Rothenberg. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. Journal of Allergy and Clinical Immunology 2012; 129(4): 1064 doi: 10.1016/j.jaci.2012.01.060
|
19 |
NAIJIAN ZHANG, HAILONG FU, LEILEI SONG, YOUHONG DING, XIUFANG WANG, CHAO ZHAO, YIQI ZHAO, FENG JIAO, YAPING ZHAO. MicroRNA-100 promotes migration and invasion through mammalian target of rapamycin in esophageal squamous cell carcinoma. Oncology Reports 2014; 32(4): 1409 doi: 10.3892/or.2014.3389
|
20 |
Rihong Zhai, Yongyue Wei, Li Su, Geoffrey Liu, Mathew H. Kulke, John C. Wain, David C. Christiani. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status. Carcinogenesis 2015; 36(1): 87 doi: 10.1093/carcin/bgu228
|
21 |
Abhayjit Singh, Cathrine DeMars, Navtej S. Buttar. . Progress in Molecular Biology and Translational Science 2010; 96: 63 doi: 10.1016/B978-0-12-381280-3.00003-8
|
22 |
Beatriz Revilla-Nuin, Pascual Parrilla, Juan Jose Lozano, Luisa F. Martínez de Haro, Angeles Ortiz, Carlos Martínez, Vicente Munitiz, David Ruiz de Angulo, Juan Bermejo, Joaquin Molina, María L. Cayuela, José Yélamos. Predictive Value of MicroRNAs in the Progression of Barrett Esophagus to Adenocarcinoma in a Long-Term Follow-up Study. Annals of Surgery 2013; 257(5): 886 doi: 10.1097/SLA.0b013e31826ddba6
|
23 |
Mirte Mayke Streppel, Shweta Pai, Nathaniel R. Campbell, Chaoxin Hu, Shinichi Yabuuchi, Marcia Irene Canto, Jean S. Wang, Elizabeth A. Montgomery, Anirban Maitra. microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1
. Clinical Cancer Research 2013; 19(15): 4067 doi: 10.1158/1078-0432.CCR-13-0601
|
24 |
Ondrej Slaby, Josef Srovnal, Lenka Radova, Jan Gregar, Jaroslav Juracek, Pavla Luzna, Marek Svoboda, Marian Hajduch, Jiri Ehrmann. Dynamic changes in microRNA expression profiles reflect progression of Barrett’s esophagus to esophageal adenocarcinoma. Carcinogenesis 2015; 36(5): 521 doi: 10.1093/carcin/bgv023
|
25 |
Xiangyi Kong, Shun Gong, Lijuan Su, Chen Li, Yanguo Kong. Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas. Journal of Cellular and Molecular Medicine 2018; 22(1): 123 doi: 10.1111/jcmm.13300
|
26 |
Ru-Gang Zhang, Chang-Song Wang, Cun-Fang Gao. Prevalence and Pathogenesis of Barrett's Esophagus in Luoyang, China. Asian Pacific Journal of Cancer Prevention 2012; 13(5): 2185 doi: 10.7314/APJCP.2012.13.5.2185
|
27 |
Roger Yazbeck, Simone E Jaenisch, David I Watson. From blood to breath: New horizons for esophageal cancer biomarkers. World Journal of Gastroenterology 2016; 22(46): 10077-10083 doi: 10.3748/wjg.v22.i46.10077
|
28 |
Audrey K. C. Huong, Kim Gaik Tay, Xavier T. I. Ngu. Five-Class Classification of Cervical Pap Smear Images: A Study of CNN-Error-Correcting SVM Models. Healthcare Informatics Research 2021; 27(4): 298 doi: 10.4258/hir.2021.27.4.298
|
29 |
Zewu Li, Lutao Du, Zhaogang Dong, Yongmei Yang, Xin Zhang, Lili Wang, Juan Li, Guixi Zheng, Ailin Qu, Chuanxin Wang, Xin-Yuan Guan. MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity. PLOS ONE 2015; 10(1): e0116170 doi: 10.1371/journal.pone.0116170
|
30 |
James Saller, Kun Jiang, Yin Xiong, Sean J. Yoder, Kevin Neill, Jose M. Pimiento, Luis Pena, F. Scott Corbett, Anthony Magliocco, Domenico Coppola. A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. Digestive Diseases and Sciences 2022; 67(2): 516 doi: 10.1007/s10620-021-06863-0
|
31 |
Uday C. Ghoshal, Dipti Chourasia. Genetic factors in the pathogenesis of gastroesophageal reflux disease. Indian Journal of Gastroenterology 2011; 30(2): 55 doi: 10.1007/s12664-011-0095-7
|
32 |
Radu Albulescu, Monica Neagu, Lucian Albulescu, Cristiana Tanase. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Review of Molecular Diagnostics 2011; 11(1): 101 doi: 10.1586/erm.10.106
|
33 |
Loveena Sreedharan, George C Mayne, David I Watson, Timothy Bright, Reginald V Lord, Alfiya Ansar, Tingting Wang, Jakob Kist, David StJ Astill, Damian J Hussey. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus. World Journal of Gastroenterology 2017; 23(30): 5508-5518 doi: 10.3748/wjg.v23.i30.5508
|
34 |
Ninad Oak, Rajarshi Ghosh, Kuan-lin Huang, David A. Wheeler, Li Ding, Sharon E. Plon. Framework for microRNA variant annotation and prioritization using human population and disease datasets. Human Mutation 2019; 40(1): 73 doi: 10.1002/humu.23668
|
35 |
Hai Long Fu, De Ping Wu, Xiu Fang Wang, Jian Guo Wang, Feng Jiao, Lei Lei Song, Hui Xie, Xu Yang Wen, Hu Sheng Shan, Yun Xiang Du, Ya Ping Zhao. Altered miRNA Expression is Associated with Differentiation, Invasion, and Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) in Patients from Huaian, China. Cell Biochemistry and Biophysics 2013; 67(2): 657 doi: 10.1007/s12013-013-9554-3
|